Having a further read:
"The laboratory validation study was conducted to demonstrate that the test meets the World Health Organisation’s (WHO)2 recommended guidelines for COVID-19 antigen rapid tests with an analytical sensitivity or Limit of Detection (LoD) in the range of one million virus genome copies/mL for COVID-19 antigen rapid test."
Which is about CT 25-30. But what it doesn't say is, how sensitive our test is. If we refer back to the Operon results, we are picking results in the range of 100 virus genome copies/mL, which is 10 to the power 2 or 102, where as the desirable number by WHO is 10 to the power of 4, which is 104.
If our UK trials are VTM free and as good as we think, we are SERIOUSLY onto something here. Wow.....typing this just makes me even more excited, and to make keep it short:
- Acceptable = 106
- Desirable = 104
- Operon Results = 102
Having a further read:"The laboratory validation study was...
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $67.22M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 965 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.5¢ | 2160397 | 2 |
View Market Depth
| Last trade - 14.30pm 11/11/2024 (20 minute delay) ? |
| ADO (ASX) Chart |
Day chart unavailable